Complete Up To Date Information about Excede™ For Swine.
NADA Number: 141-235 | |
| Proprietary Name |
Excede™ For Swine |
|---|---|
| Sponsor |
Pharmacia & Upjohn Co. |
| Sponsor Address |
a Division of Pfizer, Inc. 235 East 42nd St. New York, NY 10017 USA |
| Ingredients |
Ceftiofur Crystalline Free Acid |
| Species |
Swine, no use class stated or implied |
| Routes of Administration |
Intramuscular |
| Dose Form |
Liquid (suspension) |
| Drug Form |
Liquid (suspension) |
| Dispensing Status |
RX |
| Exclusivity |
Granted for the treatment of swine for respiratory disease. |
| Withdrawal Time |
Swine: 14 days before slaughter. |
|
Dosage Amount, Indications & Limitations |
522.313a Ceftiofur crystalline free acid. Specifications: Each milliliter of suspension contains 100 milligrams ceftiofur equivalents (CE). Swine Amount: 5.0 milligrams CE per kilogram of body weight by intramuscular injection in the postauricular region of the neck. Indications: For the treatment of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis, and Streptococcus suis. Limitations: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Following label use as a single treatment, a 14-day preslaughter withdrawal period is required. |
| Tolerances |
A tolerance for residues of ceftiofur in edible tissue of poultry and sheep is not required. Tolerances in swine for desfuroylceftiofur (marker residue) in edible swine tissues are 0.25 part per million in kidney (target tissue), 3 parts per million in liver, and 2 parts per million in muscle. Tolerances are established for residues of desfuroylceftiofur (marker residue) in edible cattle tissues at 0.4 parts per million in kidney (target tissue), 2 parts per million in the liver, 1 part per million in muscle, 100 parts per billion in milk. |